Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Submitted by
admin
on July 31, 2017 - 9:56pm
Source:
Fierce Pharma
News Tags:
FDA
Herceptin
biosimilars
Roche
Amgen
Teva Pharmaceutical
Allergan
Celltrion
Headline:
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Do Not Allow Advertisers to Use My Personal information
